# Severe and Prolonged Hypoglycemia Following Adrenalectomy for Pheochromocytoma: A Case Report

**Authors:** Masahiko Kawasumi, Yoshiro Sakamoto, Yuka Tosaka, Yukiko Okazaki, Shoko Furuya

PMC · DOI: 10.7759/cureus.86880 · Cureus · 2025-06-27

## TL;DR

A woman with diabetes and a pheochromocytoma experienced severe hypoglycemia after surgery, but later improved her glucose control without medication.

## Contribution

This case highlights the rare risk of postoperative hypoglycemia and long-term diabetes improvement after pheochromocytoma removal.

## Key findings

- The patient developed severe hypoglycemia after adrenalectomy despite standard preoperative care.
- Postoperative C-peptide levels increased, showing reversible beta-cell suppression from excess catecholamines.
- The patient achieved stable glycemic control with diet alone over 10 years post-surgery.

## Abstract

We report a case of a 64-year-old woman with poorly controlled diabetes mellitus who was found to have a left adrenal pheochromocytoma. Despite standard preoperative management including alpha-blockade with doxazosin, the patient developed persistent and severe hypoglycemia immediately following adrenalectomy, requiring high-rate intravenous glucose infusion. Markedly suppressed preoperative urinary C-peptide levels rapidly increased after surgery, indicating reversible beta-cell suppression due to catecholamine excess. Over a 10-year postoperative course, the patient maintained stable glycemic control with dietary therapy alone, demonstrating substantial improvement in glucose metabolism. This case highlights the rare but significant risk of postoperative hypoglycemia even under optimized perioperative conditions, and illustrates the potential for long-term improvement in diabetes following pheochromocytoma resection.

## Linked entities

- **Chemicals:** doxazosin (PubChem CID 3157)
- **Diseases:** diabetes mellitus (MONDO:0005015), pheochromocytoma (MONDO:0004974)

## Full-text entities

- **Diseases:** Pheochromocytoma (MESH:D010673), Hypoglycemia (MESH:D007003), diabetes (MESH:D003920)
- **Chemicals:** catecholamine (MESH:D002395), doxazosin (MESH:D017292), glucose (MESH:D005947), -blockade (-), C-peptide (MESH:D002096)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12301866/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12301866/full.md

## References

12 references — full list in the complete paper: https://tomesphere.com/paper/PMC12301866/full.md

---
Source: https://tomesphere.com/paper/PMC12301866